Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Evert

Showing results (121-130 of 228) with videos related to

Pageof 23
Sort By:
Hepatology (Baltimore, Md.)|February 10, 2019
Axis inhibition protein 1 (Axin1) Deletion-Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in MiceYu Qiao, Jingxiao Wang, Eylul Karagoz, et al.
Cell Death & Disease|February 12, 2019
MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironmentPan Wang, Xinhua Song, Kirsten Utpatel, et al.
Gastroenterology|December 15, 2010
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinomaDiego F Calvisi, Chunmei Wang, Coral Ho, et al.
The American Journal of Pathology|November 7, 2017
Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell CarcinomaRosemarie Krupar, Matthias G Hautmann, Ravi R Pathak, et al.
Hepatology (Baltimore, Md.)|February 25, 2025
β-Catenin regulates distinct pathways from YAP and suppresses ONECUT1 to drive hepatoblastoma development in mice and humansWeiting Liao, Yi Zhang, Jingxiao Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2015
Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascadeChunmei Wang, Li Che, Junjie Hu, et al.
Journal of Hepatology|August 31, 2021
TAZ is indispensable for c-MYC-induced hepatocarcinogenesisHaichuan Wang, Shanshan Zhang, Yi Zhang, et al.
Cell & Bioscience|April 5, 2026
Overexpression of ONECUT1 suppresses hepatoblastoma progression via modulating tumor cell growth and tumor microenvironmentYu Qiao, Meng Xu, Yanhui Wu, et al.
Journal of Hepatology|December 30, 2021
Corrigendum to 'TAZ is indispensable for c-MYC-induced hepatocarcinogenesis' [J Hepatol (2022) 123-134]Haichuan Wang, Shanshan Zhang, Yi Zhang, et al.
BMC Cancer|April 25, 2018
Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effectsStefan Munker, Michael Gerken, Petra Fest, et al.
Pageof 23

Showing results (121-130 of 228) with videos related to

Sort By:
Pageof 23
Hepatology (Baltimore, Md.)|February 10, 2019
Axis inhibition protein 1 (Axin1) Deletion-Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in MiceYu Qiao, Jingxiao Wang, Eylul Karagoz, et al.
Cell Death & Disease|February 12, 2019
MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironmentPan Wang, Xinhua Song, Kirsten Utpatel, et al.
Gastroenterology|December 15, 2010
Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinomaDiego F Calvisi, Chunmei Wang, Coral Ho, et al.
The American Journal of Pathology|November 7, 2017
Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell CarcinomaRosemarie Krupar, Matthias G Hautmann, Ravi R Pathak, et al.
Hepatology (Baltimore, Md.)|February 25, 2025
β-Catenin regulates distinct pathways from YAP and suppresses ONECUT1 to drive hepatoblastoma development in mice and humansWeiting Liao, Yi Zhang, Jingxiao Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2015
Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascadeChunmei Wang, Li Che, Junjie Hu, et al.
Journal of Hepatology|August 31, 2021
TAZ is indispensable for c-MYC-induced hepatocarcinogenesisHaichuan Wang, Shanshan Zhang, Yi Zhang, et al.
Cell & Bioscience|April 5, 2026
Overexpression of ONECUT1 suppresses hepatoblastoma progression via modulating tumor cell growth and tumor microenvironmentYu Qiao, Meng Xu, Yanhui Wu, et al.
Journal of Hepatology|December 30, 2021
Corrigendum to 'TAZ is indispensable for c-MYC-induced hepatocarcinogenesis' [J Hepatol (2022) 123-134]Haichuan Wang, Shanshan Zhang, Yi Zhang, et al.
BMC Cancer|April 25, 2018
Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effectsStefan Munker, Michael Gerken, Petra Fest, et al.
Pageof 23